73640results about How to "Reduce dosage" patented technology

The present invention provides methods of re-engineering or re-shaping an antibody from a first species, wherein the re-engineered or re-shaped antibody does not elicit undesired immune response in a second species, and the re-engineered or re-shaped antibody retains substantially the same antigen binding-ability of the antibody from the first species. In accordance with the present invention, a combinatorial library comprising the CDRs of the antibody from the first species fused in frame with framework regions derived from a second species can be constructed and screened for the desired modified antibody. In particular, the present invention provides methods utilizing low homology acceptor antibody frameworks for efficiently humanizing an antibody or a fragment thereof. The present invention also provides antibodies produced by the methods of the invention.

Provided are methods and compositions for detecting and treating normal, hypoplastic, ectopic or remnant tissue, organ or cells in a mammal. The method comprises parenterally injecting a mammalian subject, at a locus and by a route providing access to above-mentioned tissue or organ, with an composition comprising antibody/fragment which specifically binds to targeted organ, tissue or cell. The antibody/fragment may be administered alone, or labeled or conjugated with an imaging, therapeutic, cytoprotective or activating agent.

Isolated human monoclonal antibodies which specifically bind to human EGFR, and related antibody-based compositions and molecules, are disclosed. The human antibodies can be produced by a transfectoma or in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, non-human transgenic animals and hybridomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.

The invention relates to a high efficiency water treatment flocculant for drinking water and water treatment comprising a metal cation flocculant which is characterized in that the high efficiency water treatment flocculant also comprises a high efficiency adsorption component and an assistant medicament to be remixed, inwhich the weight ratio is: the high efficiency adsorption component 5-15%, the metal cation flocculant 50-85%, the assistant medicament 5-15%. The obvious characteristics of the invention are that each component can play the advantages of high intensity of the flocs of the inorganic flocculant and large flocs of the polymeric flocculant, overcomes the drawback of small flocs of the inorganic flocculant and low intensity of the flocs of the organic flocculant. The existence of the high adsorption component plays the action of adsorption of the organic compounds and heavy metal ion which are difficult to flocculat and precipitate, also plays the role of aid-coagulation, decoloration and deflavour. Thus the flocculant of the invention has advantages of good coagulation effect, large alum blossom, rapid settling velocity, good effluent quality and few dosage or the like.

The present invention encompasses novel antibodies and fragments thereof which immunospecifically bind to one or more RSV antigens and compositions comprising said antibodies and antibody fragments. The present invention encompasses methods preventing respiratory syncytial virus (RSV) infection in a human, comprising administering to said human a prophylactically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention also encompasses methods for treating or ameliorating symptoms associated with a RSV infection in a human, comprising administering to said human a therapeutically effective amount of one or more antibodies or fragments thereof that immunospecifically bind to one or more RSV antigens, wherein a certain serum titer of said antibodies or antibody fragments is achieved in said human subject. The present invention further encompasses compositions comprising antibodies or fragments thereof that immunospecifically bind to a RSV antigen, and methods using said compositions for detection or diagnosis a RSV infection.

The present invention relates to no-phosphate corrosion and scale inhibitor and its application. The no-phosphate corrosion and scale inhibitor consists of polyaspartic acid and/or polyepoxy succinic acid 10-20 wt%, polymaleic anhydride 20-30 wt%, copolymer of acrylic acid and 2-acrylamido-2-methyl propenyl sulfonic acid 15-20 wt%, zinc salt 3-5 wt%, natural organic high molecular compound 5-12 wt%, molybdate 5-8 wt%, and other components 5-20 wt%. It has excellent corrosion retarding performance, high scale inhibiting performance and environment friendship.

Method for modulating responsiveness to corticosteroids in a subject are provided. In the method of the invention, an agent which antagonizes a factor that regulates production of IFN-.gamma. in the subject is administered to the subject in combination with a corticosteroid such that responsiveness of the subject to the corticosteroid is modulated as compared to when a corticosteroid alone is administered to the subject. In one embodiment, the agent is an interferon-.gamma. inducing factor (IGIF) antagonist. In another embodiment, the agent is an interleukin-12 (IL-12) antagonist. In a preferred embodiment, the agent is an inhibitor of a caspase family protease, preferably an ICE inhibitor. In another preferred embodiment, the agent is an anti-IL-12 monoclonal antibody. Other preferred agents include phosphodiesterase IV inhibitors and beta-2 agonists. The methods of the invention can be used in the treatment of a variety of inflammatory and immunological diseases and disorders. Pharmaceutical compositions comprising an agent which antagonizes a factor that regulates production of IFN-.gamma. in a subject, a corticosteroid and a pharmaceutically acceptable carrier are also provided. A preferred composition comprises an ICE inhibitor, a corticosteroid and a pharmaceutically acceptable carrier.

The invention discloses a bactericide pesticide composite containing oligochitosan, which comprises a component A and a component B, wherein the component A is oligochitosan or a derivative of the oligochitosan; and the component B is one or several of active compounds. The pesticide composition can produce a synergistic action, reduce the dosage of a chemically synthetic bactericide, prevent or delay the medicament resistance of the bactericide, improve crop stress resistance and yield, regulate metabolic balance in plant bodies and improve quality of agricultural products, improve the application safety of the bactericide and is more safe to ecological environmental and human bodies.

The invention provides a high selectivity catalyst used for catalyzing and completely oxidizing formaldehyde with low concentration at room temperature. The catalyst can catalyze formaldehyde completely so as to lead the formaldehyde to be converted into carbon dioxide and water at room temperature. In addition, the conversion rate of formaldehyde remains 100% within a long period of time, without complex auxiliary facilities such as light source, a heating oven and the like, and external conditions. The catalyst comprises three parts which are inorganic oxide carrier, noble metal component and auxiliary ingredient. Porous inorganic oxide carrier is one of cerium dioxide, zirconium dioxide, titanium dioxide, aluminium sesquioxide, tin dioxide, silicon dioxide, lanthanum sesquioxide, magnesium oxide and zinc oxide or the mixture thereof or composite oxide thereof, zeolite, sepiolite and porous carbon materials. The noble metal component of the catalyst is at least one of platinum, rhodium, palladium, gold and silver. The auxiliary ingredient is at least one of the alkali metals of lithium, sodium, kalium, rubidium and cesium. The loading of the noble metal component used in the catalyst of the invention is 0.1 to 10% according to weight converter of metal elements and the selective preference is 0.3 to 2%. The loading of the auxiliary ingredient is 0.2 to 30% according to weight converter of metal elements and the selective preference is 1 to 10%. When the loading of the auxiliary ingredient is lower than 0.2% or higher than 30%, the activity of the catalyst for catalyzing and oxidizing formaldehyde at room temperature is decreased remarkably.

The invention discloses a special biological fish fertilizer and a preparation method for the fertilizer used in aquiculture; wherein, the biological fish fertilizer mainly comprises raw materials as follows: microbiological preparation, inorganic fertilizers, fermentation organics, micro-mineral amino acid chelate, mineral composites, and water quality improver. The preparation method for the special biological fish fertilizer in aquiculture comprises steps as follows: microbiological preparation is produced; fermentation organics is then produced, and the micro-mineral amino acid chelate is produced, eventually the finished products are made. The special biological fish fertilizer has the advantages of limiting the growth and reproduction of the harmful algae, promoting the large-scale growth and reproduction of the suitable food for fish, effectively improving the water quality and purifying the water environment, strengthening the fish immunity, reducing the diseases, reducing cost due to the small use level, convenient use, mild odor, no pollution to the water, and environment protection. By combining the modern bioengineering technique, low-temperature drying technique, spray-drying technique, and super-fine crushing techniques, the preparation method has the advantages of stable quality for the fish fertilizers and lower overall cost.

The present invention provides novel antibodies that immunospecifically bind to an IL-9 polypeptide and compositions comprising said antibodies. The present invention also provides methods and compositions preventing, treating, managing, and/or ameliorating diseases and disorders associated with aberrant expression and/or activity of IL 9 or IL-9 receptor or subunits thereof, autoimmune diseases, inflammatory diseases, proliferative diseases, and infections comprising administration of one or more antibodies thereof that immunospecifically bind to an IL-9 polypeptide. The invention also encompasses methods and compositions for diagnosing, monitoring, and prognosing these disorders. The present invention further relates to articles of manufacture and kits comprising antibodies that immunospecifically bind to an IL-9 polypeptide.

The invention discloses a particle-typed composite fertilizer of humic acid and manufacturing method, which consists of dressing and karyosome, wherein the dressing contains nitrogen, phosphor and potassium. The manufacturing method comprises the following steps: graining humic acid; cladding; graining; solidifying fused fertilizer on the particle of humic acid; making the composite fertilizer dissolved into water without falling; fitting for large scale of agricultural product.

The present invention provides chimeric negative-stand RNA viruses that allow a subject, e.g., an avian, to be immunized against two infectious agents by using a single chimeric virus of the invention. In particular, the present invention provides chimeric influenza viruses engineered to express and incorporate into their virions a fusion protein comprising an ectodomain of a protein of an infectious agent and the transmembrane and cytoplasmic domain of an influenza virus protein. Such chimeric viruses induce an immune response against influenza virus and the infectious agent. The present invention also provides chimeric Newcastle Disease viruses (NDV) engineered to express and incorporate into their virions a fusion protein comprising the ectodomain of a protein of an infectious agent and the transmembrane and cytoplasmic domain of an NDV protein. Such chimeric viruses induce an immune response against NDV and the infectious agent.

The invention relates to a special micro-fluidic chip for cholera diagnosis with one-dimensional self-assembly magnetic bead chain electrodes, belonging to the field of testing. Rapid diagnosis of fulminating infectious disease cholera with low cost is one of many expectations in the development of medical technology, and the invention provides a micro-fluidic chip for simultaneously detecting and rapidly diagnosing cholera by using multiple characteristic antibodies of cholera. The chip is provided with three micro liquid storage tanks, and the invention is characterized in that capillary passages in parallel configuration contain in the chip, the parallel configuration contains four micro-passages that are mutually in parallel, four magnetic bead chain working electrodes are respectively installed inside the four micro-passages, the surface substances of the four magnetic bead chain working electrodes are respectively four antibody substances that are cholera TP0821 antibody, cholera TP0319 antibody, cholera TP0624 antibody and cholera O139 mycoprotein antibody. The integrated structure and the appearances of specific magnetic bead chain working electrodes facilitate to improve the diagnosis efficiency of cholera diseases.

The present invention relates to traditional Chinese medicine for treating coronary heart disease and stenocardia is made from (by wt.%) salvia root 50-97%, notoginseng 2-48% and borneol 0.2-3%, in which the salvia root and notoginseng and hot extracted with water, then filtering, concentrating, alcohol precipitating, standing still, recovering ethyl alcohol, concentrating, into extractum, further blended with borneol and adjuvant polyglycol-6000 to form into product.

The invention provides a nano-bionic material for tissue repair and a preparation method thereof. The nano-bionic material comprises a nano-bionic bracket and hydrosol attached to the nano-bionic bracket, wherein one or more cell factors and/or cells are coated in the hydrosol. The preparation method of the nano-bionic material comprises the following steps of: preparing an electrospinning solution and a hydrosol solution containing the cell factors and/or the cells; preparing the nano-bionic bracket by using the electrospinning; printing the hydrosol solution containing the cell factors and/or the cells on the nano-bionic bracket by using a ink-jet printer; and the like, and repeating the electrospinning and the ink jet to obtain the nano-bionic material with different thicknesses. By combining with an electrospinning technology and a biological printing technology, the invention combines specific medicines and/or the cell factors and/or the cells in the nano-bracket and/or the surface of the nano-bracket, thereby greatly enhancing the effects of the nano-bionic material on tissue repair and tissue regeneration; in addition, the invention has broad application prospect.

The invention relates to an environment-friendly light heat-insulating material for fireproof doors and buildings, and a manufacturing method thereof. The manufacturing method is characterized by comprising the following steps of: pretreating plant hollow core bodies and/or flexible porous fillers by using a water glass adhesive; mixing with inorganic fire-resistant hollow particles; and performing mould pressing, shaping and drying to obtain the environment-friendly light heat-insulating material. The hollow core bodies and the flexible porous fillers are arranged multidirectionally; one layer of water glass adhesive is arranged at least on the surfaces of the hollow core bodies and the flexible porous fillers; and discontinuous holes are reserved between the hollow core bodies and/or the flexible porous fillers and the inorganic fire-resistant hollow particles. Preferably, the hollow core bodies are rice husks and straw sections; and the flexible porous fillers are foam and fibers. Renewable plant resources and recovered foam and fiber waste are adopted, so the environment-friendly light heat-insulating material is energy-saving and environment-friendly; and a large number of sealed holes are formed among the material particles through the penetration and coating of the modified water glass adhesive, and a heat-insulating hydrophobic corrosion-resistant multi-effect protective layer is provided, so the environment-friendly light heat-insulating material has good fireproof, heat-insulating and heat-preserving effects, high weather resistance, combined rigidity and toughness, low density and low cost.

The invention provides methods of immunotherapy of Alzheimer's and similar diseases in which the regime administered to a patient depends on the ApoE genotype of the patient.

The present invention relates to methods and compositions designed for the treatment, management, or prevention of cancer, particularly metastatic cancer and cancers of T cell origin, and hyperproliferative diseases involving EphA2-expressing cells. The methods of the invention entail the use of a Listeria-based EphA2 vaccine. The invention also provides pharmaceutical compositions comprising one or more Listeria-based vaccines of the invention either alone or in combination with one or more other agents useful for cancer therapy. In certain aspects of the invention, the methods entail eliciting both CD4⁺ and CD8⁺ T-cell responses against EphA2 and/or EphA2-expressing cells.

The present invention discloses a catalytic reaction method. Said method can make the catalytic reaction be implemented in the supergravitational field. Said method utilizes the rotary bed supergravitational field equipment as reactor, on the rotor of said rotary bed supergravitational field equipment a porous catalyst layer and/or a porous filler layer are fixed, and the described catalytic reaction is homogeneous reaction or heterogeneous reaction. Said invention cal reduce catalyst consumption, raise utilization rate of catalyst, raise stability of catalyst and can reduce denergy consumption, etc.